Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6388649 | 0.87 | AKT1 (0.46) | ALDH1A1 | |
| SCHEMBL6742956 | 0.84 | ALDH1A1 (0.41) | ALDH1A1KMT2AMMP1MMP2MMP3 | |
| SCHEMBL6742954 | 0.84 | ALDH1A1 (0.41) | ALDH1A1KMT2AMMP1MMP2MMP3 | |
| SCHEMBL6738589 | 0.81 | ELANE (0.47) | ALDH1A1KMT2AMMP1MMP2MMP3 | |
| SCHEMBL6389343 | 0.81 | ELANE (0.47) | ALDH1A1KMT2AMMP1MMP2MMP3 | |
| Hydrochloric Acid SCHEMBL6971183 | 0.80 | ELANE (0.49) | ALDH1A1KMT2AMMP1MMP2MMP3 | |
| Hydrochloric Acid SCHEMBL6971175 | 0.80 | ELANE (0.49) | ALDH1A1KMT2AMMP1MMP2MMP3 | |
| SCHEMBL31649285 | 0.79 | PPARA (0.51) | ALDH1A1 | |
| SCHEMBL7400672 | 0.76 | ALDH1A1 (0.46) | ALDH1A1KMT2AMAPTMEN1 | |
| SCHEMBL6394294 | 0.76 | ITGAV (0.45) | ALDH1A1KMT2AMMP2MMP9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2438448-B1 | MASS LABELS, KIT AND METHOD FOR MASS SPECTROMETRY ANALYSIS OF KETONE AND ALDEHYDE ANALYTES | DH TECHNOLOGIES DEV PTE LTD (SG) | 2020-05-20 | — | — | EP | disclosed |
| US-10094809-B2 | Specific analysis of ketone and aldehyde analytes using reagent compounds, labeling strategies, and mass spectrometry workflow | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2018-10-09 | — | — | US | disclosed |
| US-20170115258-A1 | SPECIFIC ANALYSIS OF KETONE AND ALDEHYDE ANALYTES USING REAGENT COMPOUNDS, LABELING STRATEGIES, AND MASS SPECTROMETRY WORKFLOW | DH TECHNOLOGIES DEV PTE LTD (SG) | 2017-04-27 | — | — | US | disclosed |
| US-9500622-B2 | Specific analysis of ketone and aldehyde analytes using reagent compounds, labeling strategies, and mass spectrometry workflow | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2016-11-22 | — | — | US | disclosed |
| US-20140004616-A1 | SPECIFIC ANALYSIS OF KETONE AND ALDEHYDE ANALYTES USING REAGENT COMPOUNDS, LABELING STRATEGIES, AND MASS SPECTROMETRY WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2014-01-02 | — | — | US | disclosed |
| US-20110003395-A1 | SPECIFIC ANALYSIS OF ANALYTES USING REAGENT COMPOUNDS, LABELING STRATEGIES, AND MASS SPECTROMETRY WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2011-01-06 | — | — | US | disclosed |
| WO-2010141075-A1 | SPECIFIC ANALYSIS OF KETONE AND ALDEHYDE ANALYTES USING REAGENT COMPOUNDS LABELING STRATEGIES, AND MASS SPECTROMETRY WORKFLOW | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2010-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003395-A1 | SPECIFIC ANALYSIS OF ANALYTES USING REAGENT COMPOUNDS, LABELING STRATEGIES, AND MASS SPECTROMETRY WORKFLOW | HSD17B7, HSD17B13, HSD11B1 | ALDH1A1 70/4885KMT2A 1328/4885MMP1 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.